Pasar al contenido principal

FARMACOS INNOVADORES PARA ENFERMEDADES NEURODEGENERATIVAS (ALZHEIMER Y ESCLEROSIS LATERAL AMIOTROFICA) ACTIVOS EN DIANAS NEUROGENICAS Y NEUROPROTECTORAS

SAF2015-64948-C2-1-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Dirección General de Investigación Científica y Técnica
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

New cinnamic – N-benzylpiperidine and cinnamic – N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties

  • Estrada, Martín
  • Herrera-Arozamena, Clara
  • Pérez, Concepción
  • Viña, Dolores
  • Romero Jódar, Alejandro
  • Morales-García, José A.
  • Pérez Castillo, Ana
  • Rodríguez-Franco, María Isabel
Here we describe new families of multi-target directed ligands obtained by linking antioxidant cinnamic-related structures with N-benzylpiperidine (NBP) or N,N-dibenzyl(N-methyl)amine (DBMA) fragments. Resulting hybrids, in addition to their antioxidant and neuroprotective properties against mitochondrial oxidative stress, are active at relevant molecular targets in Alzheimer’s disease, such as cholinesterases (hAChE and hBuChE) and monoamine oxidases (hMAO-A and hMAO-B). Hybrids derived from umbellic – NBP (8), caffeic – NBP (9), and ferulic – DBMA (12) displayed balanced biological profiles, with IC50s in the low-micromolar and submicromolar range for hChEs and hMAOs, and an antioxidant potency comparable to vitamin E. Moreover, the caffeic – NBP hybrid 9 is able to improve the differentiation of adult SGZ-derived neural stem cells into a neuronal phenotype in vitro., Financial support from the Spanish Ministry of Economy and Competitiveness (MINECO, grants SAF2012-31035 and SAF2015-64948-C2-1-R to MIRF; grant SAF2014-52940-R to APC) partially financed by FEDER funds, and Consejo Superior de Investigaciones Científicas (CSIC, grant PIE-201580E109) is gratefully acknowledged. ME thanks COLCIENCIAS (Colombia) for a Ph.D. fellowship., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases

  • Herrera-Arozamena, Clara
  • Martí-Marí, Olaia
  • Estrada, Martín
  • Fuente Revenga, Mario de la
  • Rodríguez-Franco, María Isabel
The central nervous system of adult mammals has long been considered as a complex static structure unable to undergo any regenerative process to refurbish its dead nodes. This dogma was challenged by Altman in the 1960s and neuron self-renewal has been demonstrated ever since in many species, including humans. Aging, neurodegenerative, and some mental diseases are associated with an exponential decrease in brain neurogenesis. Therefore, the controlled pharmacological stimulation of the endogenous neural stem cells (NSCs) niches might counteract the neuronal loss in Alzheimer’s disease (AD) and other pathologies, opening an exciting new therapeutic avenue. In the last years, druggable molecular targets and signalling pathways involved in neurogenic processes have been identified, and as a consequence, different drug types have been developed and tested in neuronal plasticity. This review focuses on recent advances in neurogenic agents acting at serotonin and/or melatonin systems, Wnt/β-catenin pathway, sigma receptors, nicotinamide phosphoribosyltransferase (NAMPT) and nuclear erythroid 2-related factor (Nrf2)., This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO, grants SAF2015-64948-C2-1-R and SAF2012-31035) partially financed by FEDER funds, and Consejo Superior de Investigaciones Científicas (CSIC, grant PIE-201580E109). We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

New neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition

  • Estrada, Martín
  • Pérez, Concepción
  • Soriano, Elena
  • Pricl, Sabrina
  • Morales-García, José A.
  • Pérez Castillo, Ana
  • Rodríguez-Franco, María Isabel
et al., [Background]: Neurogenic agents emerge as innovative drugs for the treatment of Alzheimer's disease (AD), whose pathological complexity suggests strengthening research in the multi-target directed ligands strategy. [Results]: By combining the lipoic acid structure with N-benzylpiperidine or N,N-dibenzyl(N-methyl)amine fragments, new multi-target directed ligands were obtained that act at three relevant targets in AD: σ-1 receptor (σR), β-secretase-1 (BACE1) and acetylcholinesterase (AChE). Moreover, they show potent neurogenic properties, good antioxidant capacity and favorable CNS permeability. Molecular modeling studies on AChE, σR and BACE1 highlight relevant drug-protein interactions that may contribute to the development of new disease-modifying drugs. [Conclusion]: New lipoic-based σ agonists endowed with neurogenic, antioxidant, cholinergic and amyloid β-peptide-reducing properties have been discovered for the potential treatment of AD., Financial support from the Spanish Ministry of Economy and Competitiveness (MINECO, grants SAF2012-31035 and SAF2015-64948 to MIRF; grants SAF2010-16365 and SAF2014-52940-R to APC), Fundación de Investigación Médica Mutua Madrileña Automovilística (grant AP103952012 to MIRF), and Consejo Superior de Investigaciones Científicas (CSIC, grant PIE-201580E109 to MIRF) is gratefully acknowledged. ME thanks COLCIENCIAS (Colombia) for a Ph.D. fellowship. ES, and EL and SP thank CESGA (Santiago de Compostela, Spain) and CINECA (Bologna, Italy – Project SIMBIOSY) supercomputer centres, respectively, for providing access to computational resources., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro

  • Morales-García, José A.
  • Fuente Revenga, Mario de la
  • Alonso-Gil, Sandra
  • Rodríguez-Franco, María Isabel
  • Feilding, Amanda
  • Pérez Castillo, Ana
  • Riba, Jordi
Banisteriopsis caapi is the basic ingredient of ayahuasca, a psychotropic plant tea used in the Amazon for ritual and medicinal purposes, and by interested individuals worldwide. Animal studies and recent clinical research suggests that B. caapi preparations show antidepressant activity, a therapeutic effect that has been linked to hippocampal neurogenesis. Here we report that harmine, tetrahydroharmine and harmaline, the three main alkaloids present in B. caapi, and the harmine metabolite harmol, stimulate adult neurogenesis in vitro. In neurospheres prepared from progenitor cells obtained from the subventricular and the subgranular zones of adult mice brains, all compounds stimulated neural stem cell proliferation, migration, and differentiation into adult neurons. These findings suggest that modulation of brain plasticity could be a major contribution to the antidepressant effects of ayahuasca. They also expand the potential application of B. caapi alkaloids to other brain disorders that may benefit from stimulation of endogenous neural precursor niches., This work was supported by the MINECO (Grants SAF2010-16365 and SAF2014-52940-R to A.P-C and grants SAF2012-31035 and SAF2015-64948-C2-1-R to M.I.R.-F.), and was partially financed with FEDER funds. J.R. received funding from the Beckley Foundation. CIBERNED is funded by the Instituto de Salud Carlos III. J.A.M-G. is a post-doctoral fellow from CIBERNED, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease

  • Estrada, Martín
  • Herrera-Arozamena, Clara
  • Andrés, Lucía de
  • Pérez, Concepción
  • Morales-García, José A.
  • Pérez Castillo, Ana
  • Ramos, Eva
  • Romero Jódar, Alejandro
  • Viña, Dolores
  • Yáñez, Matilde
  • Laurini, E.
  • Pricl, Sabrina
  • Rodríguez-Franco, María Isabel
In this work we describe neurogenic and neuroprotective donepezil-flavonoid hybrids (DFHs), exhibiting nanomolar affinities for the sigma-1 receptor and inhibition of key enzymes in Alzheimer's disease (AD), such as acetylcholinesterase (AChE), 5-lipoxygenase (5-LOX), and monoamine oxidases (MAOs). In general, new compounds scavenge free radical species, are predicted to be brain-permeable, and protect neuronal cells against mitochondrial oxidative stress. N-(2-(1-Benzylpiperidin-4-yl)ethyl)-6,7-dimethoxy-4-oxo-4H-chromene-2-carboxamide (18) is highlighted due to its interesting biological profile in sigma1R, AChE, 5-LOX, MAO-A and MAO-B. In phenotypic assays, it protects a neuronal cell line against mitochondrial oxidative stress and promotes maturation of neural stem cells into a neuronal phenotype, which could contribute to the reparation of neuronal tissues. Molecular modelling studies of 18 in AChE, 5-LOX and sigma-1R revealed the main interactions with these proteins, which will be further exploited in the optimization of new, more efficient DFHs., Financial supports from the Spanish Ministry of Economy, Industry, and Competitiveness (MEICOM, grant SAF2015-64948-C2- 1-R to MIRF; grant SAF2014-52940-R to APC), Consejo Superior de Investigaciones Científicas (CSIC, grant PIE-201580E109 to MIRF), and Dirección General de Investigación e Innovación de la Comunidad de Madrid (DGII-CM, grant B2017/BMD-3827, acronym NRF24AD-CM to MIRF) are gratefully acknowledged. DV thanks financial support from the Consellería de Cultura, Educación e Ordenación Universitaria, Centro Singular de Investigación de Galicia and the European Regional Development Fund (ERDF) (accreditation 2016e2019, ED431G/05). MEV and CH-A thank their Ph.D. fellowships from COLCIENCIAS (Colombia) and MEC (FPU16/ 01704, Spain), respectively, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors

  • Reis, J.
  • Cagide, F.
  • Estrada Valencia. Martín
  • Teixeira, J.
  • Bagetta, D.
  • Pérez, Concepción
  • Uriarte, Eugenio
  • Oliveira, Paulo J.
  • Ortuso, F.
  • Alcaro, S.
  • Rodríguez-Franco, María Isabel
  • Borges, Fernanda
There has been a substantial research effort to design multi-target ligands for the treatment of Alzheimer's disease (AD), an approach that is moved by the knowledge that AD is a complex and multifactorial disease affecting many linked to pathological pathways. Accordingly, we have devoted efforts to develop multi-target ligands based on the chromone scaffold. As a result, a small library of chromone derivatives was synthesized and screened towards human cholinesterases and monoamine oxidases. Compounds 2-(dimethylamino)ethyl (E)-3-(4-oxo-2-(p-methylphenlcarbamoyl)-4H-chromen-6-yl)acrylate (9a) and 2-(dimethylamino)ethyl (E)-3-(4-oxo-3-(phenylcarbamoyl)-4H-chromen-6-yl)acrylate (23a) were identified as the most promising multi-target inhibitors of the series. Compound 9a acted as a potent, selective and bifunctional AChEI (IC50 = 0.21 mM, Ki = 0.19 mM) and displayed dual hMAO inhibitory activity (hMAO-A IC50 = 0.94 mM, Ki = 0.057 mM and hMAO-B IC50 = 3.81 mM, Ki = 0.48 mM). Compound 23a acted as a selective IMAO-B (IC50 = 0.63 mM, Ki = 0.34 mM) while still displaying hChE inhibitory and bifunctional activity in the low micromolar range. Overall, these two compounds stand out as reversible multi-target inhibitors with favourable permeability, toxicological and drug-like profiles, thus being valid candidates for subsequent optimization and pre-clinical studies., This work was funded by Foundation for Science and Technology, FEDER/COMPETE and Norte Portugal Regional Operational Programme (UID/QUI/00081, POCI-01-0145-FEDER-006980, POCI- 01-0145-FEDER-007440, POCI-01-0145-FEDER-016659). J Reis, F. Cagide and J. Teixeira grants are supported by FCT, POPH, FEDER/ COMPETE and Norte2020. M.I.R.-F. acknowledges the financial support from the following Spanish Agencies: Ministry of Economy, Industry and Competitiveness (grant SAF2015-64948-C2-1-R), Comunidad de Madrid (grant B2017/BMD-3827) and Consejo Superior de Investigaciones Científicas (grant PIE-201580E109). The authors also thank the COST action CA15135 for support., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

New flavonoid–N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer's disease endowed with neurogenic properties

  • Estrada, Martín
  • Herrera-Arozamena, Clara
  • Pérez, Concepción
  • Viña, Dolores
  • Morales-García, José A.
  • Pérez Castillo, Ana
  • Ramos, Eva
  • Romero Jódar, Alejandro
  • Laurini, E.
  • Pricl, Sabrina
  • Rodríguez-Franco, María Isabel
The design of multi-target directed ligands (MTDLs) is a valid approach for obtaining effective drugs for complex pathologies. MTDLs that combine neuro-repair properties and block the first steps of neurotoxic cascades could be the so long wanted remedies to treat neurodegenerative diseases (NDs). By linking two privileged scaffolds with well-known activities in ND-targets, the flavonoid and the N,N-dibenzyl(N-methyl)amine (DBMA) fragments, new CNS-permeable flavonoid–DBMA hybrids (1–13) were obtained. They were subjected to biological evaluation in a battery of targets involved in Alzheimer’s disease (AD) and other NDs, namely human cholinesterases (hAChE/hBuChE), β-secretase (hBACE-1), monoamine oxidases (hMAO-A/B), lipoxygenase-5 (hLOX-5) and sigma receptors (σ R/σ R). After a funnel-type screening, 6,7-dimethoxychromone–DBMA (6) was highlighted due to its neurogenic properties and an interesting MTD-profile in hAChE, hLOX-5, hBACE-1 and σ R. Molecular dynamic simulations showed the most relevant drug-protein interactions of hybrid 6, which could synergistically contribute to neuronal regeneration and block neurodegeneration., The authors gratefully acknowledge the following financial supports: Spanish Ministry of Science, Innovation and Universities (grants SAF2015-64948-C2-1-R and RTI2018-093955-B-C21 to MIRF; grant SAF2017-85199-P to APC), Spanish National Research Council (CSIC, grant PIE-201580E109 to MIRF), General Council for Research and Innovation of the Community of Madrid and European Structural Funds (grant B2017/BMD-3827 – NRF24ADCM to MIRF), Consellería de Cultura, Educación e Ordenación Universitaria de Galicia, and the European Regional Development Fund (ERDF) (accreditation 2016–2019, ED431G/05 to DV). EL and SP gratefully acknowledge the support of NVIDIA Corporation with the donation of the Titan Xp GPU used for this research. and CH-A also thank their PhD fellowships from Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS, Colombia) and Spanish Ministry of Education (MEC, grant FPU16/01704), respectively. JAM-G is a fellow from the Biomedical Research Networking Centre on Neurodegenerative Diseases (CIBERNED, Spain)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Neurogenic inducers based on the chromone scaffold, a new family of multitarget directed ligands for Alzheimer's disease

  • Estrada, Martín
  • Herrera-Arozamena, Clara
  • Andrés, Lucía de
  • Pérez, Concepción
  • Morales-García, José A.
  • Pérez Castillo, Ana
  • Romero Jódar, Alejandro
  • Viña, Dolores
  • Pricl, Sabrina
  • Laurini, E.
  • Rodríguez-Franco, María Isabel
Resumen del trabajo presentado a la XXXVIII Reunión Anual del Grupo Español de Neurotransmisión y Neuroprotección (GENN), celebrada en Almagro (Ciudad Real) del 13 al 15 de diciembre de 2017., The highly complex pathophysiology of Alzheimer's disease (AD) and other neurodegenerative illnesses have led to replace the traditional one-drug - one-target by the multi-target-directed ligands (MTDLs) paradigm, in which a single molecule is designed to be active against several pharmacological targets. Continuing with our interest in neuroprotective and neurogenic compounds, in this work we describe a new family of donepezil flavonoid hybrids exhibiting nanomolar affinities for the sigma-1 receptor and a combined inhibition of key enzymes in AD, such as 5-lipoxygenase, acetylcholinesterase, and monoaminoxidases. In general, they scavenge free radical species and are predicted to be brain-permeable. In phenotypic assays, new hybrids protect neuronal cells against mitochondrial oxidative stress and promote maturation of neural stem cells into a neuronal phenotype. Therefore, new donepezil - flavonoid hybrids could contribute to the protection and even, the reparation of neuronal tissues, of great therapeutic interest in AD and neurodegenerative diseases., Spanish Ministry of Economy and Competitiveness MINECO (grant SAF2015-64948-C2-1-R) and Spanish National Research Council CSIC (grant PIE-201580E109)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Synthesis of 3-indolyltriazoles via Sonogashira coupling and azide-alkyne cycloaddition promoted by supported copper nanoparticles

  • Stabile, S.
  • Vitale, C. A.
  • Rodríguez-Franco, María Isabel
In this work we present the synthesis of a novel series of 3-indolyl-1,4-disubstituted 1,2,3-triazoles. The key steps in the synthetic route are shown in Scheme 1. A series of N-protected 3-iodoindoles were subjected to a Sonogashira cross-coupling reaction with trimethylsilylacetylene in presence of PdCl2(PPh)3 and CuI as catalysts and TEA as base, following the procedures described by Boger [1]. After deprotection of the silyl group, 1,2,3-triazoles were obtained through the azide-alkyne Huisgen 1,3-dipolar cycloaddition catalysed by copper nanoparticles (CuNPs) immobilized on activated carbon, which were prepared using the CuCl2-Li-4,4¿-Di-tert-butylbiphenyl (DTBB) reducing system previously reported by our group [2]., This work was performed in the Instituto de Química Médica (IQM-CSIC) with grants from the following agencies: Dirección General de Investigación e Innovación de la Comunidad de Madrid y Fondo Europeo de Desarrollo Regional (B2017/BMD-3827); Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación y FEDER (SAF2015-64948-C2-1-R and RTI2018-093955-B-C21); Universidad Nacional del Sur, programa de Pasantías en Centros de Investigación destinada a Jóvenes Docentes.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Surface plasmon resonance for the discovery of new non-electrophilic inhibitors of KEAP1-NRF2 protein-protein interaction

  • Estrada-Valencia, M.
  • Herrera-Arozamena, Clara
  • Lagartera, Laura
  • Cuadrado, Antonio
  • Fernández-Ginés, Raquel
  • García-Yagüe, Ángel Juan
  • Morales-García, J. A.
  • Pérez-Castillo, Amalia
  • Rodríguez-Franco, María Isabel
In recent years the nuclear transcription factor (erythroid-derived 2)¿like 2 (Nrf2) has been identified as the key factor in the cell auto-protection mechanisms. Under no pathological conditions, Nrf2 is mainly located in the cytosol, bound to the Kelch like ECH associated protein 1 (Keap1). In contrast, under oxidative conditions, Keap1 changes its conformation and breaks the binding with Nrf2 allowing its accumulation and translocation to the nucleus where it induces the transcription of key antioxidant enzymes. Nrf2 dysregulation is involved in different pathologies such as cancer, cardiovascular diseases or neurodegenerative diseases, among others [1]. In recent years, a great amount of new molecules able to disrupt the interaction between Nrf2 and Keap1, have been studied, however most of them are electrophilic molecules and are prone to interact with several non-desired targets. In our group we are applying the surface plasmon resonance (SPR) technique for the identification of new non-electrophilic inhibitors of the Nrf2 - Keap1 protein-protein interaction (PPI). This kind of molecules could exhibit a more specific mechanism for the induction of Nrf2 activity. Thus, the ability of several molecules from our library to interact with the purified Kelch domain of Keap1 attached to a CM5 sensor chip has been evaluated in a SPR assay [2]. With this technique, a new hit with affinity for Keap1 was identified. The affinity value was comparable to that of the positive control ML-334, a well-known inhibitor of the Nrf2 - Keap1 PPI. Starting from this new hit, a larger family with improved potency have been obtained [3]. This new family of bis-heterocyclic compounds do not present any electrophilic character, are able to reach the central nervous system and exhibit other complementary activities such as radical scavenging and neurogenic properties, which make them potential candidates for the treatment of neurodegenerative diseases such as Alzheimer¿s disease., Dirección General de Investigación e Innovación de la Comunidad de Madrid y Fondo Europeo de Desarrollo Regional (B2017/BMD-3827, NRD24AD-CM); Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación y FEDER (SAF2015-64948-C2-1-R, RTI2018-093955-B-C21
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Lewis acid-catalysed oligomerization of methoxy- or ciano-indoles: synthesis of potential biologically active compounds

  • Sempere-Pérez, I.
  • Estrada-Valencia, M.
  • Rodríguez-Franco, María Isabel
Compounds containing the indole nucleus show an extensive assortment of biological and pharmacological activities, including analgesic, antiallergic, antibacterial, anti-HIV, antitumor, and antioxidant properties [1,2]. Recently, the synthesis and anticancer properties of alkaloids with dimeric indole scaffolds were reported [3]. Therefore, our interest was focused on the study of the oligomerization reactions of 4-, 6- and 7- substituted indoles with electron donor groups, i.e. methoxy group, and electron withdrawing groups, i.e. nitrile group, using a Lewis acid (bismuth chloride). From our results, we concluded that indole oligomerization is sensitive to the substituent on the heterocycle. Both the substituent position and the inductive effects of the substituents, determine which products and in which ratio they are formed. We were also able to propose possible mechanisms for the reaction that can explain the different products obtained for each substrate. ., Dirección General de Investigación e Innovación de la Comunidad de Madrid y Fondo Europeo de Desarrollo Regional (B2017/BMD-3827); Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación y FEDER (SAF2015-64948-C2-1-R and RTI2018-093955-B-C21); Consejo Superior de Investigaciones Científicas (JAE-Intro18_EX-0264 a I.S.-P.)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

New neurogenic inducers with combined activities in key targets related to Alzheimer¿s disease

  • Herrera-Arozamena, Clara
  • Estrada-Valencia, M.
  • Pérez, Concepción
  • Viña, D.
  • Michalska, Patrycja
  • León, Rafael
  • López, M. G.
  • Morales-García, J. A.
  • Pérez-Castillo, Amalia
  • Rodríguez-Franco, María Isabel
Alzheimer¿s Disease (AD) is a complex multifactorial illness with no effective cure, characterized by the irreversible memory loss and global cognitive impairment. Given that the marketed drugs act only at one single target, being a symptomatic treatment, exploration of new molecules acting in different pathways is required. In this sense, we have developed a large family of multitarget directed ligands (MTDL), which interacts in different targets related to neurodegeneration, such as the nuclear factor (erythroid-derived 2)-like 2 (Nrf2), lipoxygenase-5 (LOX-5), melatonin receptors (MT1, MT2, and MT3), and monoamine oxidases (MAO-A and MAO-B). The affinity or inhibition constants of these compounds in such targets are in the nanomolar and micromolar ranges. In general, these molecules have potent antioxidant properties (ORAC assay) and are able to penetrate into the central nervous system (CNS) by passive diffusion (PAMPA-BBB assay). Moreover, some of them are able to promote neurogenesis in vitro by inducing the maturation of neural stem cells into a neuronal phenotype. A structure-activity relationship has been stablished, reaching an optimized structure as possible candidate to treat AD, able to cross the blood brain barrier, reaching the CNS where it would act in three targets involved in the regulation of oxidative stress, as Nrf2 inducer, MT3 ligand and selective MAO B inhibitor. Furthermore, this MTDL is an effective neuroprotective and neurogenic agent., Dirección General de Investigación e Innovación de la Comunidad de Madrid y Fondo Europeo de Desarrollo Regional (B2017/BMD-3827); Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación y FEDER (SAF2015-64948-C2-1-R and RTI2018-093955-B-C21). C.H.-A. thanks Spanish Ministry of Education for a FPU fellowship (grant FPU16/01704)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structure-activity relationship of potent photo-switchable neuromuscular inhibitors

  • Herrera-Arozamena, Clara
  • Estrada-Valencia, M.
  • Villalba-Galea, C. A.
  • Rodríguez-Franco, María Isabel
Muscular nicotinic acetylcholine receptors (nAChR) are ligand-gated ion channels located in the plasma membrane of the post-junctional motor endplate in skeletal muscles. These receptors are responsible for triggering the electrical signal that leads to muscle contraction. Here, we have developed a family of photoisomerizable nAChR inhibitors, using the azobenzene scaffold. Biochemical assays showed that all these novel compounds have higher affinity for muscular nAChR (up to 60-fold) than for either ¿7 or ¿4ß2 nAChRs. Thus, we proceeded to characterize the action of these compounds on the activity of the embryonic muscular nAChR expressed in Xenopus oocytes. To do so, we recorded currents evoked by acetylcholine, using the Two-Electrode Voltage-Clamp technique. In doing so, we observed that all but one of the compounds were effective inhibitors of the receptor¿s activity. As reported elsewhere, azobenzene-based molecules can be as either cis- or trans-isomers, displaying remarkable difference in their pharmacology. To test whether the isomer had different inhibitory activity, we proceeded to irradiate the drugs with either near UV (335-365 nm) or blue light (400-450 nm) while recording currents. In all cases, we observed that the trans-isomers were the most potent form of these molecules. The main difference among the compounds of this family is the ¿molecular volume¿ of the functional group. The molecules were effective inhibitors of the receptor with nano- to micromolar activity, decreasing their potency as their size decrease. In fact, the trans-isomer of the smallest derivative reverting its behavior, acting as an agonist drug, with the cis-isomer being unable to activate the channels. In terms structure-activity relationship (SAR) parameters, these observations led us to infer the that decreasing the bulkiness of the molecule is a critical determinant of the character and potency of these novel azobenzene-based inhibitors., MINECO (SAF2015-64948-C2-1-R; CHA: FPU16/01704; FPUEST17/00233), CSIC (PIE201580E109), Nutting Foundation Grant (CAVG).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Optical control of muscular nicotinic channels with azocuroniums, photoswitchable azobenzenes bearing two N-methyl-N-carbocyclic quaternary ammonium groups

  • Herrera-Arozamena, Clara
  • Estrada-Valencia, M.
  • Martí-Marí, Olaia
  • Pérez, Concepción
  • Fuente Revenga, Mario de la
  • Villalba-Galea, C. A.
  • Rodríguez-Franco, María Isabel
By linking two N-methyl-N-carbocyclic quaternary ammonium groups to an azobenzene scaffold in meta- or para-positions we generated a series of photoswitchable neuromuscular ligands for which we coined the term “azocuroniums”. These compounds switched between the (E)- and (Z)-isomers by light irradiation at 400–450 nm and 335–340 nm, respectively. Meta-azocuroniums were potent nicotinic ligands with a clear selectivity for the muscular nAChRs compared to neuronal α7 and α4β2 subtypes, showed good solubility in physiologic media, negligible cell toxicity, and would not reach the CNS. Electrophysiological studies in muscle-type nAChRs expressed in Xenopus laevis oocytes showed that (E)-isomers were more potent than (Z)-forms. All meta-azocuroniums were neuromuscular blockers, with the exception of the pyrrolidine derivative that was an agonist. These new meta-azocuroniums, which can be modulated ad libitum by light, could be employed as photoswitchable muscle relaxants with fewer side effects for surgical interventions and as tools to better understand the pharmacology of muscle-type nAChRs., The authors gratefully acknowledge the following financial supports: Spanish Ministry of Science, Innovation and Universities; Spanish Research Agency; and European Regional Development Funds (grants SAF2015-64948-C2-1-R and RTI2018-093955-B-C21 to MIRF), General Council for Research and Innovation of the Community of Madrid and European Structural Funds (grant S2017/ BMD-3827 e NRF24ADCM to MIRF) and Spanish National Research Council CSIC (grant PIE-202080E118). CH-A also thanks her PhD fellowships from Spanish Ministry of Education (MEC, PhD grant FPU16/01704 and mobility grant FPUEST17/00233).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties

  • Herrera-Arozamena, Clara
  • Estrada-Valencia, M.
  • Pérez, Concepción
  • Lagartera, Laura
  • Morales-García, José A.
  • Pérez-Castillo, Ana
  • Franco-Gonzalez, Juan Felipe
  • Michalska, Patrycja
  • Duarte, Pablo
  • León, Rafael
  • López, Manuela G.
  • Mills, Alberto
  • Gago, Federico
  • García-Yagüe, Ángel Juan
  • Fernández-Ginés, Raquel
  • Cuadrado, Antonio
  • Rodríguez-Franco, María Isabel
New multi-target indole and naphthalene derivatives containing the oxadiazolone scaffold as a bioisostere of the melatonin acetamido group have been developed. The novel compounds were characterized at melatonin receptors MTR and MTR, quinone reductase 2 (QR2), lipoxygenase-5 (LOX-5), and monoamine oxidases (MAO-A and MAO-B), and also as radical scavengers. We found that selectivity within the oxadiazolone series can be modulated by modifying the side chain functionality and co-planarity with the indole or naphthalene ring. In phenotypic assays, several oxadiazolone-based derivatives induced signalling mediated by the transcription factor NRF2 and promoted the maturation of neural stem-cells into a neuronal phenotype. Activation of NRF2 could be due to the binding of indole derivatives to KEAP1, as deduced from surface plasmon resonance (SPR) experiments. Molecular modelling studies using the crystal structures of QR2 and the KEAP1 Kelch-domain, as well as the recently described X-ray free-electron laser (XFEL) structures of chimeric MTR and MTR, provided a rationale for the experimental data and afforded valuable insights for future drug design endeavours., The authors gratefully acknowledge the following financial supports: Spanish Ministry of Science, Innovation and Universities; Spanish Research Agency; and European Regional Development Funds (grants RTI2018-093955-B-C21 and SAF2015-64948-C2-1-R to M.I.R.-F.; RTI2018-095793-B-I00 to M.G.L., SAF2015-64629-C2-2-R to F.G.), General Council for Research and Innovation of the Community of Madrid and European Structural Funds (grant B2017/BMD-3827 e NRF24ADCM), Health Institute Carlos III (Miguel Servet II ProgramCP16/00014 and grant PI17/01700 to R.L.). CH-A and P.M. thank their PhD fellowships from Spanish Ministry of Education (MEC, PhD grant FPU16/01704 and mobility grant FPUEST17/00233 to CH-A and FPU13/03737 to P.M.).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades

  • Herrera-Arozamena, Clara
  • Estrada-Valencia, M.
  • López-Caballero, Patricia
  • Pérez, Concepción
  • Morales-García, José A.
  • Pérez-Castillo, Ana
  • Sastre, Eric del
  • Fernández-Mendívil, Cristina
  • Duarte, Pablo
  • Michalska, Patrycja
  • Lombardía, José
  • Senar, Sergio
  • León, Rafael
  • López, Manuela G.
  • Rodríguez-Franco, María Isabel
By replacing a phenolic ring of (E)-resveratrol with an 1,3,4-oxadiazol-2(3H)-one heterocycle, new resveratrol-based multi- target-directed ligands (MTDLs) were obtained. They were evaluated in several assays related to oxidative stress and inflammation (monoamine oxidases, nuclear erythroid 2-related factor, quinone reductase-2, and oxygen radical trapping) and then in experiments of increasing complexity (neurogenic properties and neuroprotection vs okadaic acid). 5-[(E)-2-(4-Methoxyphenyl)ethenyl]-3-(prop-2-yn-1- yl)-1,3,4-oxadiazol-2(3H)-one (4e) showed a well-balanced MTDL profile: cellular activation of the NRF2-ARE pathway (CD = 9.83 μM), selective inhibition of both hMAO-B and QR2 (IC50s = 8.05 and 0.57 μM), and the best ability to promote hippocampal neurogenesis. It showed a good drug-like profile (positive in vitro central nervous system permeability, good physiological solubility, no glutathione conjugation, and lack of PAINS or Lipinski alerts) and exerted neuroprotective and antioxidant actions in both acute and chronic Alzheimer models using hippocampal tissues. Thus, 4e is an interesting MTDL that could stimulate defensive and regenerative pathways and block early events in neurodegenerative cascades., The authors gratefully acknowledge the following financial supports: the Spanish Ministry of Science, Innovation and Universities; Spanish Research Agency; European Regional Development Funds (grants RTI2018-093955-B-C21, SAF2015-64948-C2-1-R, and PID2021-122650OB-I00 to M.I.R.-F.; RTI2018-095793-B-I00 to M.G.L.); Spanish Na- tional Research Council (CSIC grants, PIE-202080E118 to M.I.R.-F. and PIE-202080I026 to R.L.); Health Institute Carlos III (grant PI17/01700 to R.L.); and General Council for Research and Innovation of the Community of Madrid and European Structural Funds (grant B2017/BMD-3827- NRF24ADCM). They thank the Ministry of Education of Spain for the following fellowships: FPU16/01704 and mobility grant FPUEST17/00233 (to C.H.-A.), FPU15/ 03269 (to C.F.-M.), FPU18/00630 (to E.d.S.), and FPU13/ 03737 (to P.M.). R.L. and M.G.L. also thank “Fundación Teófilo Hernando” for its continued support. The Spanish Medicinal Chemistry Society (SEQT) awarded the “Lilly Prize for Young Researchers” to this work, presented by C.H.-A. at the XIX SEQT Awards., Peer reviewed
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties

  • Herrera Arozamena, Clara
  • Estrada Valencia, Martín
  • Pérez, Concepción
  • Lagartera Ortiz, Laura
  • Morales García, Jose Ángel
  • Pérez Castillo, Ana
  • Franco Gonzalez, Juan Felipe
  • Michalska, Patrycja
  • Duarte Flórez, Pablo
  • León Martínez, Rafael
  • García López, Manuela
  • Mills Fernández, Alberto|||0000-0003-4819-1638
  • Gago Badenas, Federico|||0000-0002-3071-4878
  • García Yagüe, Ángel Juan
  • Fernández Ginés, Raquel
  • Cuadrado Pastor, Antonio
  • Rodríguez Franco, María Isabel
24 p., New multi-target indole and naphthalene derivatives containing the oxadiazolone scaffold as a bioisostere of the melatonin acetamido group have been developed. The novel compounds were characterized at melatonin receptors MT1R and MT2R, quinone reductase 2 (QR2), lipoxygenase-5 (LOX-5), and monoamine oxidases (MAO-A and MAO-B), and also as radical scavengers. We found that selectivity within the oxadiazolone series can be modulated by modifying the side chain functionality and co-planarity with the indole or naphthalene ring. In phenotypic assays, several oxadiazolone-based derivatives induced signalling mediated by the transcription factor NRF2 and promoted the maturation of neural stem-cells into a neuronal phenotype. Activation of NRF2 could be due to the binding of indole derivatives to KEAP1, as deduced from surface plasmon resonance (SPR) experiments. Molecular modelling studies using the crystal structures of QR2 and the KEAP1 Kelch-domain, as well as the recently described X-ray free-electron laser (XFEL) structures of chimeric MT1R and MT2R, provided a rationale for the experimental data and afforded valuable insights for future drug design endeavours., Ministerio de Ciencia, Innovación y Universidades, Agencia Española de Investigación, Fondo Europeo de Desarrollo Regional (FEDER), Comunidad de Madrid, Instituto de Salud Carlos III, Ministerio de Educación y Ciencia, Ministerio de Economía y Competitividad